Related Experiment Videos
Alterations of MAPK activities associated with intestinal cell differentiation
1Department of Surgery, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555, USA.
Biochemical and Biophysical Research Communications
|June 8, 2001
Summary
Sodium butyrate induces differentiation and cell death in colon cancer cells by altering mitogen-activated protein kinase (MAPK) activity. ERK pathway inhibition and JNK pathway activation are key to these processes.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitogen-activated protein kinases (MAPKs), including ERK, JNK, and p38, are crucial regulators of cellular differentiation and apoptosis.
- Understanding MAPK involvement in intestinal cell differentiation and apoptosis is vital for cancer research.
Purpose of the Study:
- To investigate the role of MAPK pathways in sodium butyrate (NaBT)-induced differentiation and apoptosis in human colon cancer cell lines (Caco-2 and HT29).
Main Methods:
- Assessed intestinal alkaline phosphatase (IAP) activity as a marker of differentiation.
- Measured MAPK (ERK, JNK1, p38) activity and c-Jun phosphorylation.
- Utilized MEK inhibitor PD98059 in combination with NaBT.
Main Results:
- NaBT treatment increased IAP activity and induced cell death in Caco-2 and HT29 cells.
- ERK activity decreased during differentiation, while JNK1 activity and c-Jun phosphorylation increased.
- p38 activity showed a transient increase following NaBT treatment.
- Inhibiting MEK potentiated NaBT's effects on IAP activity and cell death.
Conclusions:
- ERK pathway inhibition and JNK pathway activation are critical components of NaBT-mediated intestinal cell differentiation and apoptosis.
- MAPK signaling pathways are significantly altered during NaBT-induced colon cancer cell differentiation and apoptosis.